Skip to main content
. 2003 Jan;77(2):1564–1570. doi: 10.1128/JVI.77.2.1564-1570.2003

FIG. 6.

FIG. 6.

Lipopeptide presentation in the presence of epoxomycin. The experiment was conducted like that shown in Fig. 5 except that epoxomycin was used instead of brefeldin A. Results are representative of three independent experiments. The average response in the presence of epoxomycin compared to the uninhibited control was, for anti-Nef73-82 responses, 133% ± 10% for Nef73-82 versus 130 ± 33% for lipopeptide Nef66-97 (not significant); for anti-Pol476-484 responses, 120% ± 51% for Pol476-484 versus 34% ± 26% for lipopeptide Pol461-484 (P < 0.03).